Header image

Poster Tour 03: Liver health, fibrosis and advanced disease

Tracks
Track 1
Friday, August 14, 2026
10:55 AM - 11:25 AM
Poster Boards: 1-4

Speaker

Agenda Item Image
VH2026

Welcome & Introduction

10:55 AM - 11:00 AM

Biography

Dr David Goodman
Senior Research Associate
Kirby Institute

To Screen or Not to Screen, before DAA Therapy? A Decision Curve Analysis of Age-Based Fibrosis Screening Strategies

11:00 AM - 11:05 AM

Abstract (.pdf)

Biography

Dr. David Goodman-Meza is a Senior Research Associate at the Kirby Institute in the University of New South Wales and a Staff Specialist at St Vincent's Hospital Sydney and Parklea Correctional Centre. He is a specialist in Infectious Diseases and Addiction Medicine.
Agenda Item Image
Ms Kirsty Rundle
Senior Registered Nurse
Health Nz

Getting on track and doing what we should: Addressing gaps in Hepatitis C treatment within Mental Health Services

11:05 AM - 11:10 AM

Abstract (.pdf)

Biography

Kirsty has over 30 years nursing experience primarily within mental health services with the last 10 years having specialised in physical health outcomes for consumers within Specialist Mental Health Services Te Whatu Ora Waitaha Canterbury.
Agenda Item Image
Dr Heather Valerio
Research Fellow
The Kirby Institute, UNSW Sydney

Reductions in prevalence of advanced liver fibrosis among people who inject drugs in the direct-acting antiviral era: The ETHOS Engage Study

11:10 AM - 11:15 AM

Abstract (.pdf)

Biography

Heather is a postdoctoral research fellow in the Viral Hepatitis Clinical Research Program at the Kirby Institute. Her main area of focus is enhancing the equity of viral hepatitis elimination, particularly for people who inject drugs, women, children, and other populations who are underserved by the current standard of care.
Agenda Item Image
Dr Anna Hawkes
CEO
Hepatitis Queensland

Liver cancer and viral hepatitis in Queensland – a new report.

11:15 AM - 11:20 AM

Abstract (.pdf)

Biography

Adjunct Associate Professor Anna Hawkes is CEO of Hepatitis Queensland. She has over 30 years’ executive experience leading policy, research and program delivery championing equitable health outcomes for marginalised communities.

Chairperson

Mel Rhagnath
Program Manager
Ashm

loading